Reserpine/Clopamide/ Dihydroergocristine
Therapeutic agent (verify pharmacological class)
What it is used for
Essential hypertension; arterial and renal hypertension. Clinical selection for Reserpine/Clopamide/ Dihydroergocristine should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Impaired hepatic and/or renal func- tions; diabetes; gout; monitored serum potassium and uric acid levels; epilepsy; concurrent admin- istration with levodopa; cardiac infarction; cardiac damage.
Possible side effects
Postural hypotension; blood dyscra- sia; headache; GI disturbances; flushing; depression; suicidal tendency; nasal congestion; glycosuria in diabetes; gout; muscle spasm; dry mouth; parkinson-like syndrome; increased appetite; loss of libido.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.